Der er efter markedsføring rapporteret om interstitiel lungesygdom (herunder pneumonitis og pulmonal fibrose), nogle med dødelig udgang.
There have been postmarketing reports of interstitial lung disease (including pneumonitis and pulmonary fibrosis), some of which had fatal outcomes.